Next-Generation Immunotherapies to Improve Anticancer Immunity

Checkpoint inhibitors are widely used immunotherapies for advanced cancer. Nonetheless, checkpoint inhibitors have a relatively low response rate, work in a limited range of cancers, and have some unignorable side effects. Checkpoint inhibitors aim to reinvigorate exhausted or suppressed T cells in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yaoyao, Tomczak, Katarzyna, Li, June, Ochieng, Joshua K., Lee, Younghee, Haymaker, Cara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831045/
https://www.ncbi.nlm.nih.gov/pubmed/33505304
http://dx.doi.org/10.3389/fphar.2020.566401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831045/
https://www.ncbi.nlm.nih.gov/pubmed/33505304
http://dx.doi.org/10.3389/fphar.2020.566401

Ejemplares similares